IROC survey finds widespread single-isocenter brain radiosurgery but major variation in margins and QA

Among 879 SRS programs, 91% treated multiple lesions, while only 18.8% reported additional machine-specific QA for multi-lesion treatments.

KEY POINTS

  • The Imaging and Radiation Oncology Core (IROC) surveyed radiotherapy programs through an additional 13-question SRS questionnaire, distributed alongside its annual institutional survey between January 2021 and March 2022. A total of 879 institutions with an active SRS program responded, providing information on multi-lesion treatment, single-isocenter delivery, GTV-to-PTV margins, image guidance, and machine-specific quality assurance. The survey was developed in the context of AAPM Task Group 362 on multi-lesion radiosurgery.
  • Multi-lesion radiosurgery was widely adopted: 789/879 programs (91%) reported treating more than one lesion during a single course, while 133 programs (15%) had treated more than 15 lesions in one course. Among 605 institutions using MLC-equipped linear accelerators, 504 (83%) reported treating multiple targets with a single isocenter. Approximately 49.3% treated two to four lesions per isocenter, while 9.4% had treated more than 15 lesions using a single isocenter.
  • GTV-to-PTV margins varied substantially across programs. Among 774 responding institutions, 35% used margins greater than 0 but ≤1 mm, 46% used >1 to ≤2 mm, 10% used no expansion, and approximately 8% used margins >2 mm. Furthermore, 61% of institutions reported using the same margins for single-target and multi-target techniques, even though rotational errors can affect peripheral targets more substantially as their distance from the isocenter increases.
  • Six-degree-of-freedom positioning was strongly associated with single-isocenter multi-target delivery. A 6DOF treatment couch was used by 84.1% of single-isocenter multi-lesion programs, compared with 50.8% of programs treating one lesion per isocenter (p<0.01). Among programs reporting zero-margin SRS, 100% used a 6DOF couch, whereas only 55.3% of programs using margins >2 mm did so. These associations reflect institutional practice rather than direct evidence that zero margins are clinically safe.
  • Intrafraction monitoring approaches were heterogeneous. Among single-isocenter multi-lesion programs, commonly reported methods included surface guidance (33.6%), stereoscopic room-based kV imaging (24.3%), and CBCT (22.5%). Intrafraction monitoring was reported more frequently in single-isocenter multi-lesion programs than in single-lesion programs, but the difference was not statistically significant. Every zero-margin program reporting these details used some form of intrafraction monitoring, although monitoring frequency and intervention thresholds were not standardized.
  • Additional machine-specific QA was not routinely reported. Among 774 responding multi-lesion programs, only 147 (18.8%) performed additional machine-specific tests for their multi-lesion SRS workflow; the corresponding proportion among single-isocenter programs was 22.8%. Three-dimensional ionization-chamber or diode-array measurements were the most common patient-specific pretreatment QA approach, selected by 294/779 programs (38%). These findings expose variation in how departments address the additional complexity of treating multiple off-axis targets.
  • The results reflect voluntary, self-reported practice from 2021–2022, rather than an audit of treatment accuracy or current adoption in 2026. Centers affiliated with the NCI clinical trials network may overrepresent larger or academically active programs, and participation in the SRS addendum was optional. No patient-level positioning errors, treatment failures, toxicity outcomes, or comparative delivery accuracy were collected, so the survey cannot determine which institutional approaches are safest.

CLINICAL TAKEAWAY

Multi-lesion SRS, particularly single-isocenter delivery, is widely used but implemented with considerable differences in PTV margins, intrafraction monitoring, and additional machine-specific QA. The IROC survey provides a practical benchmark for departmental self-assessment and development of AAPM guidance, while emphasizing that reported practice patterns are not equivalent to validated technical standards or clinical safety evidence.

SOURCE

Practical Radiation Oncology

Browse more research Suggest a correction